The effectiveness of iron supplementation for postpartum depression: A protocol for systematic review and meta-analysis

Yanran Tian, Zeyu Zheng, Chen Ma2020 · DOI

Abstract

Postpartum depression (PPD) represents a significant public health challenge, affecting maternal well-being and infant development. Iron deficiency, common after childbirth due to blood loss, has been hypothesized as a contributing factor. This protocol outlines a systematic review and meta-analysis designed to evaluate the efficacy of iron supplementation in treating PPD by synthesizing evidence from randomized controlled trials (RCTs).

Introduction

Postpartum depression (PPD) is a complex mental health condition that affects a substantial portion of new mothers globally. Beyond the immediate impact on the mother's quality of life, PPD can have long-term consequences for infant bonding and developmental outcomes. While the etiology of PPD is multifactorial, nutritional status—specifically iron levels—has emerged as a potential modifiable risk factor. Iron deficiency is prevalent in the postpartum period due to the physiological demands of pregnancy and blood loss during delivery.

Despite several studies investigating the link between iron and depressive symptoms, clinical evidence remains fragmented and sometimes contradictory. Some trials report significant improvements in mood following iron therapy, while others show negligible effects. There is currently a lack of a centralized, rigorous synthesis of these findings. This protocol establishes a transparent, pre-registered roadmap for a systematic review and meta-analysis to determine whether iron supplementation is an effective therapeutic intervention for PPD.

Methodology

The proposed review will adhere to standard evidence-based medicine guidelines to ensure a rigorous and unbiased synthesis of data.

Search Strategy and Study Selection

A comprehensive search will be conducted across seven major international and Chinese-specific databases, including PubMed, Embase, the Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and the Chinese Biomedical Literature Database (CBM). The search period extends from the inception of each database through December 31, 2020.

The review will exclusively include Randomized Controlled Trials (RCTs) involving participants diagnosed with PPD. No restrictions will be placed on the route of iron administration (oral vs. intravenous), dosage, or duration of treatment.

Quality Assessment and Data Synthesis

Two independent reviewers will assess the internal validity of the included studies using the Cochrane Risk of Bias tool. This assessment will cover critical domains such as randomization, allocation concealment, blinding, and attrition.

Statistical analysis will be performed using Review Manager 5.3. The primary outcome measure will be the Edinburgh Postnatal Depression Scale (EPDS) score. For continuous data, Mean Difference (MD) will be employed, while Risk Ratios (RR) will be used for dichotomous outcomes. Heterogeneity among studies will be evaluated using the $I^2$ test. If significant heterogeneity is detected ($I^2 > 50\%$), a random-effects model will be applied to account for inter-study variation.

Discussion and Expected Impact

This protocol highlights several key strengths in its design. By including major Chinese biomedical databases, the review aims to capture a significant volume of clinical data that is often overlooked in Western-centric meta-analyses. Furthermore, the planned subgroup analyses based on administration routes (oral vs. intravenous) and dosages will provide granular insights into the most effective treatment protocols.

As a protocol, this document does not present final results. However, the eventual findings of this systematic review will have significant clinical implications. If a strong therapeutic benefit is identified, it could lead to the integration of routine iron screening and supplementation into standard postpartum mental health care. Conversely, if no significant effect is found, it will allow researchers and clinicians to redirect resources toward other evidence-based interventions for PPD.

Conclusion

This systematic review and meta-analysis protocol provides a rigorous framework for evaluating iron supplementation as a treatment for postpartum depression. By synthesizing global evidence, the resulting study aims to offer a definitive, evidence-based answer to a critical question in maternal health.

Summary updated

Abstract

Review question / Objective: To evaluate the evidence of randomized controlled trials (RCTs) for iron supplementation treatment of postpartum depression (PPD).Condition being studied: Iron supplem e n t a t i o n , p o s t p a r t u m d e p re s s i o n , protocol, systematic review, meta-analysis.
BibTeX
@misc{tian2020effectiveness,
  author = {Yanran Tian and Zeyu Zheng and Chen Ma},
  title = {{The effectiveness of iron supplementation for postpartum depression: A protocol for systematic review and meta-analysis}},
  year = {2020},
  doi = {10.37766/inplasy2020.11.0007},
}
Figure